NervGen to host inaugural R&D Day webcast on NVG-291 program
NGEN•Webcast scheduled for Sept. 30
NervGen scheduled an inaugural R&D Day webcast for Sept. 30, 2026, starting at 10 a.m. ET.
The session will outline the NVG-291 program, including clinical data to date and the design of the Phase 3 RESTORE registrational study.
Registration is available via the company website at https://www.nervgen.com.
